BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13720490)

  • 1. [First results obtained with the use of the spirolactone SC-9420 (aldactone) in the treatment of ascites caused by liver cirrhosis].
    DE FILIPPIS V; MARSICO F; PEDICINI S
    Riforma Med; 1960 Dec; 74():1516-20. PubMed ID: 13720490
    [No Abstract]   [Full Text] [Related]  

  • 2. [Association of the diuretic actions of delta-cortisone and spirolactone in the treatment of cirrhotic edema].
    VESIN P; CATTAN R
    Bull Mem Soc Med Hop Paris; 1960 Oct 14-21; 76():1005-12. PubMed ID: 13781048
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of 30 cases of ascitic cirrhosis with spirolactone. Clinical and biological studies].
    VESIN P; GIBOUDEAU ; RENAULT H; CATTAN R
    Bull Mem Soc Med Hop Paris; 1960 Oct 14-21; 76():997-1005. PubMed ID: 13781052
    [No Abstract]   [Full Text] [Related]  

  • 4. [Spirolactone (Aldactone) in ascites caused by liver cirrhosis].
    van DOMMELEN C; LE POOLE A; VAANDRAGER H; SCHOPMAN W; WADMAN SK
    Ned Tijdschr Geneeskd; 1962 Jul; 106():1481-6. PubMed ID: 13887135
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diuretic effect of spironolactone (Sc-9420) in patients with cirrhosis of the liver with ascites].
    RIVERA A; SEPULVEDA B; LANDA L; CHAGOYA L
    Rev Med Chil; 1961 Oct; 89():843-6. PubMed ID: 14038707
    [No Abstract]   [Full Text] [Related]  

  • 6. Spironolactone (Aldactone) therapy for ascites due to cirrhosis of the liver.
    LOCKWOOD CH
    Can Med Assoc J; 1961 Sep; 85(11):631-7. PubMed ID: 13763007
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [First results obtained with the use of the spirolactone SC-9420 (aldactone) in the treatment of cardiac edema].
    MARSICO F; DE FILIPPIS V; PEDICINI S
    Riforma Med; 1960 Dec; 74():1433-7. PubMed ID: 13767248
    [No Abstract]   [Full Text] [Related]  

  • 9. [The "elevation of kaliemia-azotemia-oliguria" syndrome in ascitic cirrhosis. Mechanism and therapeutic results (failure of spirolactones)].
    VESIN P; GIBOUDEAU ; RENAULT H; CATTAN R
    Bull Mem Soc Med Hop Paris; 1960 Oct 14-21; 76():1013-21. PubMed ID: 13781051
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic use of ion exchange resins in the treatment of liver cirrhosis with ascites and edema].
    Concours Med; 1954 Mar; 76(13):1315-8. PubMed ID: 13150737
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of ascites due to cirrhosis of the liver controlled by ionexchange resins.
    GRANT CW
    Practitioner; 1957 Jul; 179(1069):75-6. PubMed ID: 13453098
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of adult patients with ascites due to cirrhosis.
    Runyon BA;
    Hepatology; 2004 Mar; 39(3):841-56. PubMed ID: 14999706
    [No Abstract]   [Full Text] [Related]  

  • 13. [Closed extra corporal concentration and reinfusion of ascites in cirrhosis of liver patients with refractory ascites].
    Liu LM; Chi YC; Zhu D; Yang XM; Sun LH
    Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):314. PubMed ID: 15161521
    [No Abstract]   [Full Text] [Related]  

  • 14. The management of ascites and hyponatremia in cirrhosis.
    Ginès P; Cárdenas A
    Semin Liver Dis; 2008 Feb; 28(1):43-58. PubMed ID: 18293276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of refractory ascites: systems for ascites depuration].
    Valbonesi M; Torre GC; Ferrari M; Amato A; Abete M
    Minerva Med; 1987 May; 78(10):685-8. PubMed ID: 3587716
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic strategies for cirrhosis with ascites recommended by the American Association for Study of Liver Diseases].
    Cui Y; Jia JD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):572-3. PubMed ID: 15387924
    [No Abstract]   [Full Text] [Related]  

  • 17. [TIPS is a life-prolonging treatment of those cirrhosis patients with ascites who can not be treated medically or with paracentesis].
    Aalykke C; Tønner-Nielsen D; Vilstrup H
    Ugeskr Laeger; 2005 Oct; 167(44):4197; author reply 4198-9. PubMed ID: 16266584
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies of diuresis caused by hydrochlorothiazide].
    CASSANO A; CONTI F; COSTA C; CORDOVA C
    Riforma Med; 1959 Jun; 73(24):665-9. PubMed ID: 13675691
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of ascites in patients with end-stage liver disease.
    Saadeh S; Davis GL
    Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of ascites and hepatic hydrothorax.
    Cárdenas A; Arroyo V
    Best Pract Res Clin Gastroenterol; 2007; 21(1):55-75. PubMed ID: 17223497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.